Short Term Reproducibility of Office White-coat Effect

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 922 participants.

Also called NCT06523062

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; single masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 922 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06523062
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT06523062. Non-randomized; single masking; primary purpose diagnostic. Start 2024-09-01 (anticipated); primary completion 2025-08-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Short Term Reproducibility of Office White-coat Effect
Acronym
REBBRE
Condition
White Coat Hypertension
Intervention (Device)
blood pressure measurement
Lead sponsor
University Hospital, Caen (class: other)

Record details

Record id
cardio:ct-nct06523062
Content hash
ff90743f477e241fba23571b6dd14760e6309a94b37b066f9a303d93cb29fc99